Letting Biology Validate the EPR Imaging of Tumor pO₂

Area of Science:

• Oncology
• Radiation Oncology
• Tumor Microenvironment

Background:

• Hypoxic resistance to cytotoxins, particularly radiation, is a known challenge in cancer therapy.
• Early assumptions of universal tumor hypoxia were disproven by oxygen electrode measurements.
• Accurate quantification and localization of tumor hypoxia are crucial for effective treatment.

Purpose of the Study:

• To investigate the therapeutic advantage of targeting hypoxic tumor regions with radiation boosts.
• To compare tumor control outcomes between hypoxic and well-oxygenated tumor boosts in preclinical models.

Main Methods:

• Utilized novel radiation delivery with 3D printed apertures for isocentric tumor boosts in preclinical models.
• Employed electron paramagnetic resonance (EPR) oxygen imaging to quantify and locate tumor hypoxia.
• Delivered equivalent integral radiation doses to either hypoxic or well-oxygenated tumor subregions.

Main Results:

• Demonstrated a significant improvement in tumor control when radiation boosts were specifically targeted to hypoxic tumor areas.
• Observed a notable difference in efficacy between hypoxic boosts and boosts delivered to well-oxygenated tumor regions.
• This advantage was consistently observed across three distinct preclinical tumor models.

Conclusions:

• Targeting hypoxic tumor subregions with radiation boosts offers a significant therapeutic advantage.
• This strategy can overcome the radioresistance associated with tumor hypoxia.
• Findings support the development of precision radiation techniques for hypoxic tumors.